UBRS20152 / BTCRC BRE15-024 / O'ReganResearch Question:
Do the drugs Ribociclib and Bicalutamide help treat breast cancer?
Basic Study Information
Purpose:Location: University of Rochester Medical Center
This is an open label, multi-institutional, single arm phase II trial of ribociclib
in combination with bicalutamide in advanced AR+ triple-negative breast cancer. No
randomization or blinding is involved.
Study Reference #: STUDY00006374
Lead Researcher (Principal Investigator)
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search